Will saivotinib be included in medical insurance in 2023?

Hello dear, I am very happy to answer your question. After entering into the medical insurance, after medical insurance negotiations with the National Medical Insurance Administration of China (National Medical Insurance Administration), Verissa (Savotinib) has been included in the new version of "National Medical Insurance Administration". "Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog" (Medical Insurance Drug Catalog), used to treat disease progression after platinum-containing chemotherapy or intolerance to standard platinum-containing chemotherapy. Mesenchymal epithelial transformation factor (MET) exon 14 skip Adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). The new version of the medical insurance drug catalog will take effect from March 1, 2023.